Explore
Validate
LearnNBP2-29480
antibody from Novus Biologicals
Targeting: CXCL12
PBSF, SCYB12, SDF-1a, SDF-1b, SDF1, SDF1A, SDF1B, TLSF-a, TLSF-b, TPAR1
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- NBP2-29480 - Provider product page
- Provider
- Novus Biologicals
- Product name
- Rabbit Polyclonal CXCL12/SDF-1 alpha Antibody
- Antibody type
- Polyclonal
- Description
- CXCL12/SDF-1 alpha
- Reactivity
- Human, Rat
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 0.1 mg
- Concentration
- LYOPH
- Storage
- Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Submitted references Evaluation of the expression of the stromal cell-derived factor-1 alpha (CXCL 12) in psoriatic patients after treatment with Methotrexate.
Synergistic anti-tumor efficacy of sorafenib and fluvastatin in hepatocellular carcinoma.
DPP4 inhibition attenuates filtration barrier injury and oxidant stress in the zucker obese rat.
Abdelaal NH, Elhefnawy NG, Abdulmonem SR, Sayed S, Saleh NA, Saleh MA
Journal of cosmetic dermatology 2020 Jan;19(1):253-258
Journal of cosmetic dermatology 2020 Jan;19(1):253-258
Synergistic anti-tumor efficacy of sorafenib and fluvastatin in hepatocellular carcinoma.
Cheng Y, Luo R, Zheng H, Wang B, Liu Y, Liu D, Chen J, Xu W, Li A, Zhu Y
Oncotarget 2017 Apr 4;8(14):23265-23276
Oncotarget 2017 Apr 4;8(14):23265-23276
DPP4 inhibition attenuates filtration barrier injury and oxidant stress in the zucker obese rat.
Nistala R, Habibi J, Aroor A, Sowers JR, Hayden MR, Meuth A, Knight W, Hancock T, Klein T, DeMarco VG, Whaley-Connell A
Obesity (Silver Spring, Md.) 2014 Oct;22(10):2172-9
Obesity (Silver Spring, Md.) 2014 Oct;22(10):2172-9
No comments: Submit comment
No validations: Submit validation data